BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Du Y, Tao X, Wu J, Yu H, Yu Y, Zhao H. APOBEC3B up-regulation independently predicts ovarian cancer prognosis: a cohort study. Cancer Cell Int 2018;18:78. [PMID: 29853799 DOI: 10.1186/s12935-018-0572-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Chen Z, Wang Z, Dai Z, Hu Z, Zhang X, Hu M, Liu Z, Cheng Q. Correlation Between APOBEC3B Expression and Clinical Characterization in Lower-Grade Gliomas. Front Oncol 2021;11:625838. [PMID: 33842328 DOI: 10.3389/fonc.2021.625838] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Gansmo LB, Sofiyeva N, Bjørnslett M, Romundstad P, Hveem K, Vatten L, Dørum A, Lønning PE, Knappskog S. Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer. Sci Rep 2021;11:23463. [PMID: 34873230 DOI: 10.1038/s41598-021-02820-z] [Reference Citation Analysis]
3 Roosta Y, Sanaat Z, Nikanfar AR, Dolatkhah R, Fakhrjou A. Predictive Value of CD44 for Prognosis in Patients with Breast Cancer. Asian Pac J Cancer Prev 2020;21:2561-7. [PMID: 32986353 DOI: 10.31557/APJCP.2020.21.9.2561] [Reference Citation Analysis]
4 Xu F, Liu T, Zhou Z, Zou C, Xu S. Comprehensive Analyses Identify APOBEC3A as a Genomic Instability-Associated Immune Prognostic Biomarker in Ovarian Cancer. Front Immunol 2021;12:749369. [PMID: 34745121 DOI: 10.3389/fimmu.2021.749369] [Reference Citation Analysis]
5 Feng X, Wei Z, Tao X, Du Y, Wu J, Yu Y, Yu H, Zhao H. PLAC8 promotes the autophagic activity and improves the growth priority of human trophoblast cells. FASEB J 2021;35:e21351. [PMID: 33570788 DOI: 10.1096/fj.202002075RR] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 King JJ, Borzooee F, Im J, Asgharpour M, Ghorbani A, Diamond CP, Fifield H, Berghuis L, Larijani M. Structure-Based Design of First-Generation Small Molecule Inhibitors Targeting the Catalytic Pockets of AID, APOBEC3A, and APOBEC3B. ACS Pharmacol Transl Sci 2021;4:1390-407. [PMID: 34423273 DOI: 10.1021/acsptsci.1c00091] [Reference Citation Analysis]
7 Gara SK, Tyagi MV, Patel DT, Gaskins K, Lack J, Liu Y, Kebebew E. GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3. Oncotarget 2020;11:3354-70. [PMID: 32934779 DOI: 10.18632/oncotarget.27703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Zhou J, Du Y, Lu Y, Luan B, Xu C, Yu Y, Zhao H. CD44 Expression Predicts Prognosis of Ovarian Cancer Patients Through Promoting Epithelial-Mesenchymal Transition (EMT) by Regulating Snail, ZEB1, and Caveolin-1. Front Oncol 2019;9:802. [PMID: 31497537 DOI: 10.3389/fonc.2019.00802] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
9 Yamazaki H, Shirakawa K, Matsumoto T, Hirabayashi S, Murakawa Y, Kobayashi M, Sarca AD, Kazuma Y, Matsui H, Maruyama W, Fukuda H, Shirakawa R, Shindo K, Ri M, Iida S, Takaori-Kondo A. Endogenous APOBEC3B Overexpression Constitutively Generates DNA Substitutions and Deletions in Myeloma Cells. Sci Rep 2019;9:7122. [PMID: 31073151 DOI: 10.1038/s41598-019-43575-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
10 Vile RG, Melcher A, Pandha H, Harrington KJ, Pulido JS. APOBEC and Cancer Viroimmunotherapy: Thinking the Unthinkable. Clin Cancer Res 2021;27:3280-90. [PMID: 33558423 DOI: 10.1158/1078-0432.CCR-20-1888] [Reference Citation Analysis]
11 Yamazaki H, Shirakawa K, Matsumoto T, Kazuma Y, Matsui H, Horisawa Y, Stanford E, Sarca AD, Shirakawa R, Shindo K, Takaori-Kondo A. APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression. PLoS One 2020;15:e0223463. [PMID: 31914134 DOI: 10.1371/journal.pone.0223463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]